Net Assets for West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's latest reported net assets is $2.99B USD. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingNet AssetsSwitch metric
Latest period
$2.99B
YoY change
+18.4%
5Y CAGR
+11.4%
Peak year (2025)
$3.18B
Latest annual
$3.18B
Net Assets history chart for West Pharmaceutical Services (WST) from 1985 to 2025
Net Assets history table for West Pharmaceutical Services (WST) from 1985 to 2025
| Fiscal year | Period ended | Reported | Net Assets | YoY |
|---|---|---|---|---|
| 2025 | $3.18B | +18.4% | ||
| 2024 | $2.68B | -6.9% | ||
| 2023 | $2.88B | +7.3% | ||
| 2022 | $2.68B | +15.0% | ||
| 2021 | $2.34B | +25.9% | ||
| 2020 | $1.85B | +17.9% | ||
| 2019 | $1.57B | +12.7% | ||
| 2018 | $1.40B | +9.1% | ||
| 2017 | $1.28B | +14.5% | ||
| 2016 | $1.12B | +9.1% | ||
| 2015 | $1.02B | +7.0% | ||
| 2014 | $956.90M | +5.6% | ||
| 2013 | $906.40M | +24.4% | ||
| 2012 | $728.90M | +11.3% | ||
| 2011 | $654.90M | +4.7% | ||
| 2010 | $625.70M | +8.0% | ||
| 2009 | $579.10M | +18.9% | ||
| 2008 | $487.10M | +0.4% | ||
| 2007 | $485.30M | +17.1% | ||
| 2006 | $414.50M | +24.3% | ||
| 2005 | $333.50M | +10.8% | ||
| 2004 | $301.10M | +16.9% | ||
| 2003 | $257.60M | +27.8% | ||
| 2002 | $201.50M | +14.0% | ||
| 2001 | $176.80M | -13.7% | ||
| 2000 | $204.80M | -11.4% | ||
| 1999 | $231.20M | +0.5% | ||
| 1998 | $230.10M | -17.1% | ||
| 1997 | $277.70M | +10.2% | ||
| 1996 | $252.00M | -0.8% | ||
| 1995 | $254.10M | +11.8% | ||
| 1994 | $227.30M | +20.8% | ||
| 1993 | $188.10M | +11.6% | ||
| 1992 | $168.60M | +10.4% | ||
| 1991 | $152.70M | -13.3% | ||
| 1990 | $176.10M | -2.0% | ||
| 1989 | $179.70M | +4.8% | ||
| 1988 | $171.40M | +10.0% | ||
| 1987 | $155.80M | +12.2% | ||
| 1986 | $138.90M | +16.2% | ||
| 1985 | $119.50M | — |
Net Assets values are taken from West Pharmaceutical Services's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, West Pharmaceutical Services (WST) reported net assets of $3.18B – grew 18.4% year-over-year.
Across 2020–2025 (5 years), West Pharmaceutical Services net assets produced a CAGR of +11.4% – with the latest reading among the more recent periods of the dataset.
The dataset's maximum net assets sits at $3.18B (2025); the minimum reading of $119.50M dates to 1985.
West Pharmaceutical Services (WST) sits 8th of 8 Healthcare peers we track on this metric, against a peer median of $50.64B.
West Pharmaceutical Services Net Assets by Year
West Pharmaceutical Services Net Assets 2025: $3.18B
West Pharmaceutical Services net assets in 2025 was $3.18B, grew 18.4% from 2024. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Net Assets 2024: $2.68B
West Pharmaceutical Services net assets in 2024 was $2.68B, declined 6.9% below 2023.
West Pharmaceutical Services Net Assets 2023: $2.88B
West Pharmaceutical Services net assets in 2023 was $2.88B, grew 7.3% from 2022.
West Pharmaceutical Services Net Assets 2022: $2.68B
West Pharmaceutical Services net assets in 2022 was $2.68B, grew 15.0% from 2021.
West Pharmaceutical Services Net Assets 2021: $2.34B
West Pharmaceutical Services net assets in 2021 was $2.34B.
See more financial history for West Pharmaceutical Services (WST).
Sector peers — Net Assets
Companies in the same sector as West Pharmaceutical Services, ranked by their latest net assets.
| Company | Net Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $194.05B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $94.11B | Healthcare |
| Johnson & Johnson (JNJ) | $81.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.61B | Healthcare |
| AstraZeneca PLC (AZN) | $48.67B | Healthcare |
| Eli Lilly and Company (LLY) | $26.54B | Healthcare |
| Amgen Inc. (AMGN) | $8.66B | Healthcare |
| AbbVie Inc. (ABBV) | -$3.27B | Healthcare |
Frequently asked questions
What is West Pharmaceutical Services's net assets?
- Latest reported net assets for West Pharmaceutical Services (WST) is $2.99B (period ending March 31, 2026).
How has West Pharmaceutical Services net assets changed year-over-year?
- West Pharmaceutical Services (WST) net assets changed +18.4% year-over-year on the latest annual filing.
What is the long-term growth rate of West Pharmaceutical Services net assets?
- West Pharmaceutical Services (WST) net assets compound annual growth rate is +11.4% over the most recent 5 years available.
When did West Pharmaceutical Services net assets hit its highest annual value?
- West Pharmaceutical Services net assets reached its highest annual value of $3.18B in 2025.
What was West Pharmaceutical Services net assets in 2024?
- West Pharmaceutical Services (WST) net assets in 2024 was $2.68B.
What was West Pharmaceutical Services net assets in 2025?
- West Pharmaceutical Services (WST) net assets in 2025 was $3.18B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
WST Overview
Company profile, financial tools, and key metrics
WST Revenue Counter
Earns $102.12 every second. See per minute, hour, and day.
WST Earnings Counter
Earns $17.21 per second net profit. See per minute, hour, and day.
WST Economic Scale
Exceeds Belize's GDP. Compare with world economies.
WST What If Invested
What if you had invested $1,000? See historical returns from any date.
WST How It Makes Money
Discover visual breakdown of $3.22B in revenue — where it comes from and where it goes.
WST Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
WST Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
WST Daily Price Character
Steady · 44.8% historical win rate (green days). Streaks & record days.
WST Buybacks
1.65% TTM buyback yield. Shareholder yield & SBC comparison.
WST Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
WST Dividend Profile
Yield: 0.29%. Safety: 6/8. See full history.
WST Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
WST Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.